Tuesday, January 29, 2019
Amgen reports Enbrel sales down 8% in Q4
Enbrel sales decreased 8% for the fourth quarter and the full year driven by lower unit demand and lower net selling price. NEUPOGEN sales decreased 40% for the fourth quarter driven by lower net selling price and lower unit demand. Sales decreased 34% for the full year driven by lower unit demand and lower net selling price.
https://thefly.com/landingPageNews.php?id=2855439
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.